- Home
- MRSN vs FMST Comparison
MRSN vs FMST Comparison
Compare MRSN & FMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRSN
- FMST
- Stock Information
- Founded
- MRSN 2001
- FMST 2005
- Country
- MRSN United States
- FMST Canada
- Employees
- MRSN N/A
- FMST N/A
- Industry
- MRSN Biotechnology: Pharmaceutical Preparations
- FMST Other Metals and Minerals
- Sector
- MRSN Health Care
- FMST Basic Materials
- Exchange
- MRSN Nasdaq
- FMST Nasdaq
- Market Cap
- MRSN 37.0M
- FMST 38.2M
- IPO Year
- MRSN 2017
- FMST N/A
- Fundamental
- Price
- MRSN $7.66
- FMST $2.99
- Analyst Decision
- MRSN Strong Buy
- FMST
- Analyst Count
- MRSN 3
- FMST 0
- Target Price
- MRSN $33.00
- FMST N/A
- AVG Volume (30 Days)
- MRSN 90.2K
- FMST 408.6K
- Earning Date
- MRSN 08-13-2025
- FMST 08-13-2025
- Dividend Yield
- MRSN N/A
- FMST N/A
- EPS Growth
- MRSN N/A
- FMST N/A
- EPS
- MRSN N/A
- FMST N/A
- Revenue
- MRSN $34,769,000.00
- FMST N/A
- Revenue This Year
- MRSN N/A
- FMST N/A
- Revenue Next Year
- MRSN N/A
- FMST N/A
- P/E Ratio
- MRSN N/A
- FMST N/A
- Revenue Growth
- MRSN 16.14
- FMST N/A
- 52 Week Low
- MRSN $5.21
- FMST $0.55
- 52 Week High
- MRSN $70.75
- FMST $5.74
- Technical
- Relative Strength Index (RSI)
- MRSN 54.20
- FMST 49.54
- Support Level
- MRSN $6.63
- FMST $2.96
- Resistance Level
- MRSN $7.25
- FMST $3.65
- Average True Range (ATR)
- MRSN 0.52
- FMST 0.25
- MACD
- MRSN 0.02
- FMST -0.00
- Stochastic Oscillator
- MRSN 65.86
- FMST 17.19
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.
About FMST Foremost Lithium Resource & Technology Ltd. Common stock
Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec. Geographically it covers Canada and United states.